This drug has a boxed warning. This is the most serious warning from the Food and Drug Administration (FDA). A boxed warning alerts doctors and patients about drug effects that may be dangerous.

January 8, 2004-- The results of the Rythmol Atrial Fibrillation Trial (RAFT), a randomized, double-blind, placebo-controlled clinical trial, published in the American Journal of Cardiology, [1] ...

Propafenone HCl 150mg, 225mg; scored tabs. Propafenone, a Class 1C antiarrhythmic drug, has local anesthetic effects and a direct stabilizing action on myocardial membranes. The electrophysiological ...

Learn everything you need to know about Propafenone-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings ...

Propafenone HCl 225mg, 325mg, 425mg; ext-rel caps. Propafenone, a Class 1C antiarrhythmic drug, has local anesthetic effects and a direct stabilizing action on myocardial membranes. The ...

Review the side-effects of Propafenone as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Dec. 1, 2004 — Flecainide or propafenone can be safely self-administered by outpatients for control of recurrent atrial fibrillation, according to the results of a study published in the Dec. 2 issue ...

Propafenone is a class IC antiarrhythmic drug that acts by blocking sodium channels and has no effect on the action potential. The success rate of a single dose of propafenone converting atrial ...

In-hospital administration of flecainide and propafenone in a single oral loading dose has been shown to be effective and superior to placebo in terminating atrial fibrillation. We evaluated the ...

To investigate the effects of diltiazem, an L-type calcium channel blocker, and propafenone, a sodium channel blocker, on the inactivation and recovery kinetics of fKv1.4, a potassium channel that ...

Catheter ablation and prophylactic antiarrhythmic drugs can successfully treat recurring atrial fibrillation (AF), but safety concerns are associated with long-term antiarrhythmic drug use. Alboni et ...

Watson Pharmaceuticals is voluntarily recalling one lot of Propafenone HCL after it discovered that the drug, which is used to irregular heartbeats, may contain more of the active ingredient than it ...